Form 4: Anteris CEO Wayne Paterson Granted 1M RSUs

Anteris Technologies Global Corp. CEO Wayne Paterson was granted 1,000,000 Restricted Stock Units, vesting over three years.

Summary

• Wayne Paterson, the Chief Executive Officer and a Director of Anteris Technologies Global Corp. (AVR), was granted 1,000,000 Restricted Stock Units (RSUs).
• Each RSU represents the right to receive one share of the company's common stock.
• The RSUs are scheduled to vest in three approximately equal annual installments on December 16, 2025, December 16, 2026, and December 16, 2027.
• The vesting of these RSUs is contingent upon Mr. Paterson's continued service to the company through each respective vesting date.

Sentiment

Score: 7

Explanation: The RSU grant is a positive for management incentive alignment and retention, which is generally viewed favorably by investors. While it implies future dilution, this is a standard and often accepted aspect of executive compensation. Overall, it represents a routine and generally positive corporate action.

Positives

• The grant of 1,000,000 Restricted Stock Units (RSUs) to CEO Wayne Paterson aligns his long-term financial interests with those of the shareholders.
• The multi-year vesting schedule, extending through December 2027, incentivizes sustained leadership and commitment to the company's strategic goals and performance.

Negatives

• The future issuance of 1,000,000 shares upon the vesting of these RSUs could result in dilution for existing shareholders, although this is a common aspect of equity-based executive compensation.

Risks

• The vesting of the Restricted Stock Units is conditional on the CEO's continued service, meaning the shares will not be received if employment ceases before the specified vesting dates.
• The ultimate value realized from the RSUs upon vesting is directly dependent on the future market price of Anteris Technologies Global Corp. common stock, which is subject to market fluctuations.

Future Outlook

The multi-year vesting schedule for the Restricted Stock Units implies an expectation of continued service from the CEO through at least December 2027, thereby aligning management incentives with the company's long-term performance and strategic objectives.

Management Comments

• Wayne Paterson signed the filing on December 5, 2025.

Industry Context

The granting of Restricted Stock Units (RSUs) to executive leadership is a standard and widely adopted practice across various industries, particularly in growth-oriented sectors like biotechnology and medical technology. This compensation strategy is designed to attract, retain, and incentivize key personnel by linking their personal wealth directly to the long-term performance and stock value of the company, aligning with common executive compensation trends.

Comparison to Industry Standards

• The grant of 1,000,000 RSUs to a CEO, with a three-year vesting schedule, is a common structure for long-term incentive plans in publicly traded companies, especially within the biotechnology and medical device sectors.
• This type of equity compensation is comparable to practices observed at peer companies such as Edwards Lifesciences (EW) or Medtronic (MDT), which frequently use RSU grants as a significant component of executive remuneration to foster long-term commitment.
• The vesting condition, tied to continued service, is a standard mechanism to ensure executive retention and commitment, mirroring strategies employed by other industry leaders like Boston Scientific (BSX) or Abbott Laboratories (ABT).

Related Party Transactions

• The grant of 1,000,000 Restricted Stock Units to CEO Wayne Paterson constitutes an executive compensation transaction between the company and a related party (its Chief Executive Officer).

Stakeholder Impact

• **Shareholders**: May experience potential future dilution upon the vesting of the RSUs, but also benefit from increased alignment of the CEO's interests with the company's long-term performance and stock value.
• **Employees**: The grant may signal stability in leadership and a commitment to long-term growth, potentially contributing to positive employee morale and confidence.
• **Management (CEO)**: Receives a significant long-term incentive award, contingent on continued service and company performance, providing a substantial future equity stake and motivation.

Next Steps

• The CEO's continued service through December 16, 2025, for the first RSU vesting.
• The CEO's continued service through December 16, 2026, for the second RSU vesting.
• The CEO's continued service through December 16, 2027, for the third and final RSU vesting.

Key Dates

Recommendation

This filing details a routine executive compensation grant, which is a standard practice for public companies to incentivize and retain key leadership. It does not present new information that would fundamentally alter the investment thesis for Anteris Technologies Global Corp. While it aligns management interests with shareholders, it doesn't provide specific operational or financial performance updates that would warrant a change in an existing 'hold' position. Investors should continue to monitor the company's core business developments.

Keywords

Anteris Technologies, AVR, Wayne Paterson, Restricted Stock Units, RSU, Executive Compensation, SEC Form 4, Insider Transaction, Stock Grant, Corporate Governance